Implementing community-engaged pharmacogenomics in Indigenous communities

Research output: Contribution to journalComment/debate

7 Scopus citations

Abstract

Innovative pharmacogenomic approaches (genetic variation related to medication response) are needed to reduce disease and disparities in Indigenous communities. We support community-based pharmacogenomics research, inclusive of Indigenous values and priorities, to improve the health and well-being of Indigenous peoples.

Original languageEnglish
Article number920
Pages (from-to)920
JournalNature Communications
Volume15
Issue number1
DOIs
StatePublished - Jan 31 2024

Funding

We thank Drs. Wylie Burke, Sara Hull, Ajay Israni, Pamala Jacobson, Bill Oetting, Kenneth Thummel, and Dave Wilson for their feedback on early drafts. We thank Tadeusz Wroblewski for his assistance with the figure. This work was supported by NIH grants R35HG011319 (K.G.C., E.L.W.), K01AI130409 (C.R.D.), P01GM116691 (E.L.W.), and R01HG009500 (E.L.W.).

Funder number
R35HG011319, K01AI130409, R01HG009500, P01GM116691

    Keywords

    • Humans
    • Pharmacogenetics
    • Delivery of Health Care
    • Health Services, Indigenous

    Fingerprint

    Dive into the research topics of 'Implementing community-engaged pharmacogenomics in Indigenous communities'. Together they form a unique fingerprint.

    Cite this